Back to Blog
Startup Strategy
Product Market Fit
B2B SaaS
Founders

Painkiller vs. Vitamin: If Your AI Startup Is Just "Nice to Have," You Are Already Dead.

Thomas McDonough

Product & Engineering

5 min read

January 28, 2026

In our Business Assessment, the most important field isn't the score—it's the Classification. Growthmind was flagged as a "Painkiller" because for early-stage founders, lack of growth is an existential threat. Here is how to tell if you are building a painkiller or just selling vitamins.


There is a brutally simple rule in B2B sales, especially when selling to startups or SMBs:

Vitamins are optional. You take them when you feel healthy and want to feel slightly better. Painkillers are mandatory. You take them when you are in agony and need the problem to stop immediately.

In the booming AI landscape of 2026, thousands of new tools are launching every week. Most of them are Vitamins. "Write emails 10% faster!" "Generate cooler images!" "Organize your Notion better!"

And most of them are going to zero.

Why? Because when the economy tightens (and it always does) or when a founder looks at their burn rate, the Vitamins are the first things to get cut.

The Survival Requirement

We built the Growthmind Reality Layer to assess startup ideas based on market signals. One of its core functions is to classify a startup's value proposition into one of three tiers:

  1. Candy: Pure entertainment or novelty. (High viral potential, zero retention).
  2. Vitamin: Optimizes an existing process. (Good to have, hard to sell).
  3. Painkiller: Solves a critical, burning problem. (Hard to build, easy to sell).

When we ran our own business model through the AI, it classified Growthmind as a Painkiller (9/10 Intensity).

Why? Because for a technical founder, lack of marketing is death. It’s not an annoyance. It’s not an optimization issue. It is the specific reason their company will fail. They have built a product, burned their savings, and realized nobody is coming. That is agony.

If your product doesn't stop a bleeding wound, you are fighting an uphill battle against churn.

The Solopreneur Boom

The "Painkiller" demand is being driven by a massive shift in the workforce: The rise of the Solopreneur and the One-Person Unicorn.

These founders are technical wizards. They can build anything. But they are often terrified of sales, bored by marketing, and overwhelmed by content creation.

They don't need a tool that helps them "write faster." They can type just fine. They need a Partner that takes the entire burden of growth off their shoulders.

  • Vitamin: An AI writing assistant. (Requires the user to prompt, edit, and think).
  • Painkiller: An Autonomous Growth Agent. (Requires the user to approve and ship).

The Solopreneur doesn't have time to learn prompt engineering. They need results. They need a co-founder, not a SaaS subscription.

The Churn Reality

Our AI's report warned us about a specific signal: "Time to Value."

For a Painkiller product, the relief must be immediate. If you take a Tylenol and your headache is still there 4 hours later, you don't take another one—you switch brands.

The report noted: "If the 14-day plan doesn't show immediate results or clear direction, retention will be near zero."

This is the danger zone for AI tools. Many promise the world but deliver generic, hallucinations-prone garbage. To be a true Painkiller, you have to work. You have to be reliable. And you have to solve the problem now.

Are You Selling Vitamins?

Ask yourself these three questions:

  1. If my servers went down for a week, would my customers lose money? (If yes: Painkiller. If no: Vitamin).
  2. Do my customers budget for this, or do they pay for it out of "discretionary" funds?
  3. Is the problem I solve in the top 3 worries my customer has when they wake up at 3 AM?

If you answered "No" to these, you are in the Vitamin zone. You are "Nice to Have."

And in a market flooded with AI noise, "Nice to Have" is a death sentence.

Pivot to Pain

If you are a Vitamin, you don't have to quit. You have to reposition.

Don't sell the feature ("We organize your notes"). Sell the relief ("We stop you from losing million-dollar ideas"). Don't sell the optimization ("We make meetings 10% shorter"). Sell the outcome ("We give your engineering team 5 hours of deep work back every week").

Find the bleeding neck. Press on it. Then sell the bandage.

Thomas McDonough

Product & Engineering at Growthmind

Ready to stop guessing?

Get your free assessment and run your first focused experiment this week.

Start Free Trial